Literature DB >> 22752456

Two malignant tumours in the anterior mediastinum positive for CD5.

C M Steger1, A Morresi-Hauf, J Krugmann, P Schirmacher, R J Rieker, G Mechtersheimer.   

Abstract

To our knowledge, the simultaneous involvement of the anterior mediastinum by a thymic carcinoma and a B-cell chronic lymphocytic leukaemia has not been reported previously. The authors describe the case of a 62-year-old man, suffering from severe bronchitis. Chest x-ray and CT scan showed a mediastinal tumour, resected short-time after diagnosis. First, standard based histological examination revealed a thymic carcinoma admixed by a dense lymphatic infiltrate. Additional immunohistochemical staining for CD5-labelled epithelial thymic carcinoma cells as well as neoplastic B cells and led in combination with blood tests to confirm the diagnosis of the composite occurrence of a thymic carcinoma and a B-cell chronic lymphocytic leukaemia.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 22752456      PMCID: PMC3034205          DOI: 10.1136/bcr.09.2009.2289

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  16 in total

1.  Thymic carcinomas, but not thymomas and carcinomas of other sites, show CD5 immunoreactivity.

Authors:  D M Dorfman; A Shahsafaei; J K Chan
Journal:  Am J Surg Pathol       Date:  1997-08       Impact factor: 6.394

2.  Usefulness of a new CD5 antibody for the diagnosis of T-cell and B-cell lymphoproliferative disorders in paraffin sections.

Authors:  D M Dorfman; A Shahsafaei
Journal:  Mod Pathol       Date:  1997-09       Impact factor: 7.842

3.  Micronodular thymoma: an epithelial tumour with abnormal chemokine expression setting the stage for lymphoma development.

Authors:  Philipp Ströbel; Mirella Marino; Martin Feuchtenberger; Anne-Sophie Rouzière; Hans Peter Tony; Ulrich Wulbrand; Reinhold Förster; Andreas Zettl; Nancy Lee Harris; Hans Kreipe; R Hubert Laeng; Hans Konrad Müller-Hermelink; Alexander Marx
Journal:  J Pathol       Date:  2005-09       Impact factor: 7.996

4.  Mucosa-associated lymphoid tissue lymphoma of the thymus: a case report with no evidence of MALT1 rearrangement.

Authors:  Nicolas Ortonne; Christiane Copie-Bergman; Philippe Remy; Marie-Hélène Delfau-Larue; Miguel A Alonso; Xavier Mariette; Judith Dierlamm; Karen Leroy; Philippe Gaulard
Journal:  Virchows Arch       Date:  2005-01-14       Impact factor: 4.064

5.  Mucosa-associated lymphoid tissue of the thymus hyperplasia vs lymphoma.

Authors:  Marie Parrens; Pierre Dubus; Marie Danjoux; Jacques Jougon; Pierre Brousset; Jean-François Velly; Antoine de Mascarel; Jean P Merlio
Journal:  Am J Clin Pathol       Date:  2002-01       Impact factor: 2.493

6.  Low-grade B-cell lymphoma of mucosa-associated lymphoid tissue arising in the thymus. A thymic lymphoma mimicking myoepithelial sialadenitis.

Authors:  P G Isaacson; J K Chan; C Tang; B J Addis
Journal:  Am J Surg Pathol       Date:  1990-04       Impact factor: 6.394

Review 7.  Primary thymic epithelial neoplasms showing combined features of thymoma and thymic carcinoma. A clinicopathologic study of 22 cases.

Authors:  S Suster; C A Moran
Journal:  Am J Surg Pathol       Date:  1996-12       Impact factor: 6.394

8.  New WHO histologic classification predicts prognosis of thymic epithelial tumors: a clinicopathologic study of 200 thymoma cases from China.

Authors:  Gang Chen; Alexander Marx; Wen-Hu Chen; Jiang Yong; Bernhard Puppe; Philipp Stroebel; Hans Konrad Mueller-Hermelink
Journal:  Cancer       Date:  2002-07-15       Impact factor: 6.860

9.  CD5 labeling of thymic carcinomas and other nonlymphoid neoplasms.

Authors:  M J Kornstein; J Rosai
Journal:  Am J Clin Pathol       Date:  1998-06       Impact factor: 2.493

10.  Composite thymoma and chronic lymphocytic leukemia/small lymphocytic lymphoma involving the anterior mediastinum.

Authors:  Joseph D Khoury; Hesham M Amin; Jeffrey L Jorgensen; Mary L Ostrowski; M G Kim Bloom; L Jeffrey Medeiros
Journal:  Arch Pathol Lab Med       Date:  2003-02       Impact factor: 5.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.